The mission of EpiPredict is to train a multidisciplinary cohort of young researchers in a new approach to fully exploit the epigenetics of complex diseases. The 12 early-stage researchers (ESRs) will focus on a narrowly defined case, Tamoxifen-induced resistance in Estrogen Receptor positive (ER+) breast cancer, considering five interacting resistance pathways. Read more…

Please visit our news page for the latest announcements and press or our Facebook or Twitter pages!

Read our first EpiPredict blog!

Written by EpiPredict fellow William Beckman and EpiPredict partner organisation Biotecture
It gives a reflection on our project and it is a preface to our public science cafe in Heidelberg on 26 January 2017.

Epigenetics, everything you always wanted to know

DKFZ, Heidelberg, DE, Thursday 26, January 2017, 13:30-17:00

Keynote speaker: Prof. Henk Stunnenberg, Radboud University Medical Centre, NL

Science café: Applying epigenetics in breast cancer treatment

Registration via eventbrite

Click here for the flyer